AU2001273108A1 - Culturing pancreatic stem cells having a specified, intermediate stage of development - Google Patents

Culturing pancreatic stem cells having a specified, intermediate stage of development

Info

Publication number: AU2001273108A1
Authority: AU; Australia
Prior art keywords: cells; serum; pancreatic; culture; medium
Prior art date: 2000-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001273108A

Other languages

English (en)

Inventor

Chang Jiang Huang

Wen-Ghih Tsang

Tianli Zheng

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AmCyte Inc

Original Assignee

AmCyte Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-06-29

Publication date

2002-01-14

2001-06-29 Application filed by AmCyte Inc filed Critical AmCyte Inc

2002-01-14 Publication of AU2001273108A1 publication Critical patent/AU2001273108A1/en

Status Abandoned legal-status Critical Current

Links

238000012258 culturing Methods 0.000 title claims description 16
210000000130 stem cell Anatomy 0.000 title description 19
238000011161 development Methods 0.000 title description 12
239000002609 medium Substances 0.000 claims description 116
238000000034 method Methods 0.000 claims description 112
210000002966 serum Anatomy 0.000 claims description 95
239000000122 growth hormone Substances 0.000 claims description 45
108010051696 Growth Hormone Proteins 0.000 claims description 44
102000018997 Growth Hormone Human genes 0.000 claims description 44
108020004999 messenger RNA Proteins 0.000 claims description 36
239000000758 substrate Substances 0.000 claims description 30
239000000203 mixture Substances 0.000 claims description 18
102000007469 Actins Human genes 0.000 claims description 17
108010085238 Actins Proteins 0.000 claims description 17
102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 claims description 17
239000001963 growth medium Substances 0.000 claims description 17
238000004113 cell culture Methods 0.000 claims description 12
230000001902 propagating effect Effects 0.000 claims description 11
238000012546 transfer Methods 0.000 claims description 11
241000124008 Mammalia Species 0.000 claims description 8
239000003102 growth factor Substances 0.000 claims description 5
230000010003 pancreatic endocrine function Effects 0.000 claims description 5
108010000521 Human Growth Hormone Proteins 0.000 claims description 3
102000002265 Human Growth Hormone Human genes 0.000 claims description 3
239000000854 Human Growth Hormone Substances 0.000 claims description 3
230000008472 epithelial growth Effects 0.000 claims description 2
102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims 7
101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 claims 7
101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 claims 1
210000004027 cell Anatomy 0.000 description 453
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 147
102000004877 Insulin Human genes 0.000 description 74
229940125396 insulin Drugs 0.000 description 74
108090001061 Insulin Proteins 0.000 description 73
239000000543 intermediate Substances 0.000 description 62
230000014509 gene expression Effects 0.000 description 34
108091003079 Bovine Serum Albumin Proteins 0.000 description 30
239000012091 fetal bovine serum Substances 0.000 description 30
229940088597 hormone Drugs 0.000 description 24
239000004017 serum-free culture medium Substances 0.000 description 24
239000000243 solution Substances 0.000 description 24
239000005556 hormone Substances 0.000 description 23
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
230000004069 differentiation Effects 0.000 description 21
239000008103 glucose Substances 0.000 description 19
230000012010 growth Effects 0.000 description 19
239000010410 layer Substances 0.000 description 19
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
238000002955 isolation Methods 0.000 description 18
210000000496 pancreas Anatomy 0.000 description 18
210000004153 islets of langerhan Anatomy 0.000 description 16
239000003550 marker Substances 0.000 description 16
230000002124 endocrine Effects 0.000 description 15
238000003556 assay Methods 0.000 description 14
230000000903 blocking effect Effects 0.000 description 14
239000000463 material Substances 0.000 description 14
230000009996 pancreatic endocrine effect Effects 0.000 description 14
108090000623 proteins and genes Proteins 0.000 description 14
210000004923 pancreatic tissue Anatomy 0.000 description 13
102000004169 proteins and genes Human genes 0.000 description 13
238000010186 staining Methods 0.000 description 13
210000001519 tissue Anatomy 0.000 description 13
230000018109 developmental process Effects 0.000 description 12
238000012423 maintenance Methods 0.000 description 12
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 11
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 11
239000006152 selective media Substances 0.000 description 11
230000035939 shock Effects 0.000 description 11
239000002356 single layer Substances 0.000 description 11
241000283690 Bos taurus Species 0.000 description 10
102400000058 Neuregulin-1 Human genes 0.000 description 10
239000000306 component Substances 0.000 description 10
210000003890 endocrine cell Anatomy 0.000 description 10
239000000284 extract Substances 0.000 description 10
230000001817 pituitary effect Effects 0.000 description 10
239000007858 starting material Substances 0.000 description 10
108010066302 Keratin-19 Proteins 0.000 description 9
108090000556 Neuregulin-1 Proteins 0.000 description 9
230000000694 effects Effects 0.000 description 9
230000008569 process Effects 0.000 description 9
230000035755 proliferation Effects 0.000 description 9
235000018102 proteins Nutrition 0.000 description 9
239000012679 serum free medium Substances 0.000 description 9
239000013589 supplement Substances 0.000 description 9
238000012360 testing method Methods 0.000 description 9
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 8
239000007640 basal medium Substances 0.000 description 8
230000001413 cellular effect Effects 0.000 description 8
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 8
239000011777 magnesium Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
230000000644 propagated effect Effects 0.000 description 8
238000000746 purification Methods 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
102000051325 Glucagon Human genes 0.000 description 7
108060003199 Glucagon Proteins 0.000 description 7
102000005157 Somatostatin Human genes 0.000 description 7
108010056088 Somatostatin Proteins 0.000 description 7
230000029087 digestion Effects 0.000 description 7
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 7
229960004666 glucagon Drugs 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
210000004940 nucleus Anatomy 0.000 description 7
230000004044 response Effects 0.000 description 7
238000000926 separation method Methods 0.000 description 7
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 7
229960000553 somatostatin Drugs 0.000 description 7
238000002054 transplantation Methods 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 6
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 6
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
239000012980 RPMI-1640 medium Substances 0.000 description 6
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
230000008901 benefit Effects 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
206010012601 diabetes mellitus Diseases 0.000 description 6
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
238000010899 nucleation Methods 0.000 description 6
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
230000010076 replication Effects 0.000 description 6
239000000523 sample Substances 0.000 description 6
230000003248 secreting effect Effects 0.000 description 6
230000000153 supplemental effect Effects 0.000 description 6
JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
239000007995 HEPES buffer Substances 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
-1 Nkx-6.1 Proteins 0.000 description 5
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000024245 cell differentiation Effects 0.000 description 5
230000010261 cell growth Effects 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
210000002919 epithelial cell Anatomy 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
230000003914 insulin secretion Effects 0.000 description 5
210000000056 organ Anatomy 0.000 description 5
239000002953 phosphate buffered saline Substances 0.000 description 5
239000002243 precursor Substances 0.000 description 5
241000894007 species Species 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
239000004382 Amylase Substances 0.000 description 4
102000013142 Amylases Human genes 0.000 description 4
108010065511 Amylases Proteins 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
102100033237 Pro-epidermal growth factor Human genes 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 4
108090000631 Trypsin Proteins 0.000 description 4
235000019418 amylase Nutrition 0.000 description 4
238000010367 cloning Methods 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
238000012136 culture method Methods 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
238000009472 formulation Methods 0.000 description 4
229960000890 hydrocortisone Drugs 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
238000011534 incubation Methods 0.000 description 4
208000028867 ischemia Diseases 0.000 description 4
239000006166 lysate Substances 0.000 description 4
230000035800 maturation Effects 0.000 description 4
239000012188 paraffin wax Substances 0.000 description 4
239000008188 pellet Substances 0.000 description 4
239000000186 progesterone Substances 0.000 description 4
229960003387 progesterone Drugs 0.000 description 4
KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
239000012588 trypsin Substances 0.000 description 4
229940088594 vitamin Drugs 0.000 description 4
229930003231 vitamin Natural products 0.000 description 4
235000013343 vitamin Nutrition 0.000 description 4
239000011782 vitamin Substances 0.000 description 4
229910000368 zinc sulfate Inorganic materials 0.000 description 4
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 3
108010039627 Aprotinin Proteins 0.000 description 3
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
241000283707 Capra Species 0.000 description 3
235000019743 Choline chloride Nutrition 0.000 description 3
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102100031940 Epithelial cell adhesion molecule Human genes 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
241000282412 Homo Species 0.000 description 3
101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 description 3
101001075374 Homo sapiens Gamma-glutamyl hydrolase Proteins 0.000 description 3
101000664737 Homo sapiens Somatotropin Proteins 0.000 description 3
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 3
235000019766 L-Lysine Nutrition 0.000 description 3
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
229930064664 L-arginine Natural products 0.000 description 3
235000014852 L-arginine Nutrition 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
239000004158 L-cystine Substances 0.000 description 3
235000019393 L-cystine Nutrition 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
229930182844 L-isoleucine Natural products 0.000 description 3
239000004395 L-leucine Substances 0.000 description 3
235000019454 L-leucine Nutrition 0.000 description 3
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
229930195722 L-methionine Natural products 0.000 description 3
229930182821 L-proline Natural products 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 3
BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
239000004473 Threonine Substances 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
102000040945 Transcription factor Human genes 0.000 description 3
229940024606 amino acid Drugs 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
230000003321 amplification Effects 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000013459 approach Methods 0.000 description 3
229960004405 aprotinin Drugs 0.000 description 3
229960001230 asparagine Drugs 0.000 description 3
229960005261 aspartic acid Drugs 0.000 description 3
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
229960003178 choline chloride Drugs 0.000 description 3
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 3
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 3
230000001143 conditioned effect Effects 0.000 description 3
210000004748 cultured cell Anatomy 0.000 description 3
229960003067 cystine Drugs 0.000 description 3
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
229910000397 disodium phosphate Inorganic materials 0.000 description 3
230000006862 enzymatic digestion Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
239000012530 fluid Substances 0.000 description 3
229960000304 folic acid Drugs 0.000 description 3
235000019152 folic acid Nutrition 0.000 description 3
239000011724 folic acid Substances 0.000 description 3
230000006870 function Effects 0.000 description 3
229960002989 glutamic acid Drugs 0.000 description 3
238000003364 immunohistochemistry Methods 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 3
229960000310 isoleucine Drugs 0.000 description 3
229960003136 leucine Drugs 0.000 description 3
229910052943 magnesium sulfate Inorganic materials 0.000 description 3
229960004452 methionine Drugs 0.000 description 3
239000011785 micronutrient Substances 0.000 description 3
235000013369 micronutrients Nutrition 0.000 description 3
238000002156 mixing Methods 0.000 description 3
229960003966 nicotinamide Drugs 0.000 description 3
235000005152 nicotinamide Nutrition 0.000 description 3
239000011570 nicotinamide Substances 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
230000037361 pathway Effects 0.000 description 3
229960003531 phenolsulfonphthalein Drugs 0.000 description 3
229960005190 phenylalanine Drugs 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
229960002429 proline Drugs 0.000 description 3
235000008160 pyridoxine Nutrition 0.000 description 3
239000011677 pyridoxine Substances 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
229960002477 riboflavin Drugs 0.000 description 3
235000019192 riboflavin Nutrition 0.000 description 3
239000002151 riboflavin Substances 0.000 description 3
229960001153 serine Drugs 0.000 description 3
210000002325 somatostatin-secreting cell Anatomy 0.000 description 3
230000006641 stabilisation Effects 0.000 description 3
238000011105 stabilization Methods 0.000 description 3
230000003068 static effect Effects 0.000 description 3
235000019157 thiamine Nutrition 0.000 description 3
239000011721 thiamine Substances 0.000 description 3
229960003495 thiamine Drugs 0.000 description 3
229960002898 threonine Drugs 0.000 description 3
229940104230 thymidine Drugs 0.000 description 3
230000007704 transition Effects 0.000 description 3
229960004799 tryptophan Drugs 0.000 description 3
229960004441 tyrosine Drugs 0.000 description 3
229960004295 valine Drugs 0.000 description 3
229940011671 vitamin b6 Drugs 0.000 description 3
QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 2
108060005980 Collagenase Proteins 0.000 description 2
102000029816 Collagenase Human genes 0.000 description 2
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
108020004414 DNA Proteins 0.000 description 2
101800003838 Epidermal growth factor Proteins 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 2
239000012981 Hank's balanced salt solution Substances 0.000 description 2
101000976075 Homo sapiens Insulin Proteins 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
239000007836 KH2PO4 Substances 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
239000004201 L-cysteine Substances 0.000 description 2
235000013878 L-cysteine Nutrition 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
108010052014 Liberase Proteins 0.000 description 2
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
101800000675 Neuregulin-2 Proteins 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
102000014736 Notch Human genes 0.000 description 2
108010070047 Notch Receptors Proteins 0.000 description 2
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 2
101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 2
102000052651 Pancreatic hormone Human genes 0.000 description 2
108700020479 Pancreatic hormone Proteins 0.000 description 2
108010067035 Pancrelipase Proteins 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
101710098940 Pro-epidermal growth factor Proteins 0.000 description 2
102100022668 Pro-neuregulin-2, membrane-bound isoform Human genes 0.000 description 2
108010057464 Prolactin Proteins 0.000 description 2
102100024819 Prolactin Human genes 0.000 description 2
239000005700 Putrescine Substances 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
102000004338 Transferrin Human genes 0.000 description 2
108090000901 Transferrin Proteins 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
239000000556 agonist Substances 0.000 description 2
229960003767 alanine Drugs 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
239000001110 calcium chloride Substances 0.000 description 2
229910001628 calcium chloride Inorganic materials 0.000 description 2
ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000007979 citrate buffer Substances 0.000 description 2
229960002424 collagenase Drugs 0.000 description 2
229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
210000004395 cytoplasmic granule Anatomy 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
230000002900 effect on cell Effects 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
230000007368 endocrine function Effects 0.000 description 2
210000000750 endocrine system Anatomy 0.000 description 2
229940116977 epidermal growth factor Drugs 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
210000003754 fetus Anatomy 0.000 description 2
239000012458 free base Substances 0.000 description 2
239000012737 fresh medium Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
108010038983 glycyl-histidyl-lysine Proteins 0.000 description 2
238000003306 harvesting Methods 0.000 description 2
GTDOPRQDTRLYAL-UHFFFAOYSA-N hydrogen peroxide;methanol Chemical compound OC.OO GTDOPRQDTRLYAL-UHFFFAOYSA-N 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
229960003444 immunosuppressant agent Drugs 0.000 description 2
230000001861 immunosuppressant effect Effects 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
238000002513 implantation Methods 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
208000014674 injury Diseases 0.000 description 2
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 2
210000003963 intermediate filament Anatomy 0.000 description 2
NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 2
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(III) nitrate Inorganic materials [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 2
230000000366 juvenile effect Effects 0.000 description 2
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
235000020778 linoleic acid Nutrition 0.000 description 2
AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
235000019136 lipoic acid Nutrition 0.000 description 2
230000002934 lysing effect Effects 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000001000 micrograph Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
230000015031 pancreas development Effects 0.000 description 2
239000004025 pancreas hormone Substances 0.000 description 2
229940032957 pancreatic hormone Drugs 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
102000013415 peroxidase activity proteins Human genes 0.000 description 2
108040007629 peroxidase activity proteins Proteins 0.000 description 2
150000002978 peroxides Chemical class 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
229940097325 prolactin Drugs 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
238000003753 real-time PCR Methods 0.000 description 2
238000012827 research and development Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
230000028327 secretion Effects 0.000 description 2
229910052711 selenium Inorganic materials 0.000 description 2
239000011669 selenium Substances 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000008399 tap water Substances 0.000 description 2
235000020679 tap water Nutrition 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
229960002663 thioctic acid Drugs 0.000 description 2
239000012581 transferrin Substances 0.000 description 2
230000008733 trauma Effects 0.000 description 2
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
239000011691 vitamin B1 Substances 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
239000008096 xylene Substances 0.000 description 2
NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
239000011686 zinc sulphate Substances 0.000 description 2
CDAISMWEOUEBRE-SHFUYGGZSA-N 1L-chiro-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O CDAISMWEOUEBRE-SHFUYGGZSA-N 0.000 description 1
ZOXZWYWOECCBSH-UHFFFAOYSA-N 4 Methyl N-ethylcathinone Chemical compound CCNC(C)C(=O)C1=CC=C(C)C=C1 ZOXZWYWOECCBSH-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
240000000662 Anethum graveolens Species 0.000 description 1
101000611570 Bos taurus Prolactin Proteins 0.000 description 1
101000766308 Bos taurus Serotransferrin Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
102000056372 ErbB-3 Receptor Human genes 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
102100020948 Growth hormone receptor Human genes 0.000 description 1
101710099093 Growth hormone receptor Proteins 0.000 description 1
102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
102000001420 Homeobox domains Human genes 0.000 description 1
108050009606 Homeobox domains Proteins 0.000 description 1
102000009331 Homeodomain Proteins Human genes 0.000 description 1
108010048671 Homeodomain Proteins Proteins 0.000 description 1
101000895818 Homo sapiens Chorionic somatomammotropin hormone 1 Proteins 0.000 description 1
101000956228 Homo sapiens Chorionic somatomammotropin hormone 2 Proteins 0.000 description 1
101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 1
101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 description 1
101001109792 Homo sapiens Pro-neuregulin-2, membrane-bound isoform Proteins 0.000 description 1
101001109765 Homo sapiens Pro-neuregulin-3, membrane-bound isoform Proteins 0.000 description 1
101001109767 Homo sapiens Pro-neuregulin-4, membrane-bound isoform Proteins 0.000 description 1
101000843556 Homo sapiens Transcription factor HES-1 Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
206010020880 Hypertrophy Diseases 0.000 description 1
101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
108010020437 Ki-67 Antigen Proteins 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100351017 Mus musculus Pax4 gene Proteins 0.000 description 1
101000686934 Mus musculus Prolactin-7D1 Proteins 0.000 description 1
102000008730 Nestin Human genes 0.000 description 1
108010088225 Nestin Proteins 0.000 description 1
101800002648 Neuregulin-1 Proteins 0.000 description 1
102400000057 Neuregulin-2 Human genes 0.000 description 1
102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 1
108050000588 Neurogenic differentiation factor 1 Proteins 0.000 description 1
101100519293 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pdx-1 gene Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
208000012868 Overgrowth Diseases 0.000 description 1
102000007354 PAX6 Transcription Factor Human genes 0.000 description 1
108010032788 PAX6 Transcription Factor Proteins 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
108010003044 Placental Lactogen Proteins 0.000 description 1
241000288906 Primates Species 0.000 description 1
102100022659 Pro-neuregulin-3, membrane-bound isoform Human genes 0.000 description 1
102100022658 Pro-neuregulin-4, membrane-bound isoform Human genes 0.000 description 1
108010076181 Proinsulin Proteins 0.000 description 1
102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
102100032733 Protein jagged-2 Human genes 0.000 description 1
101710170213 Protein jagged-2 Proteins 0.000 description 1
238000011530 RNeasy Mini Kit Methods 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
101000653754 Rattus norvegicus Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 1
101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
102100030798 Transcription factor HES-1 Human genes 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
108700042768 University of Wisconsin-lactobionate solution Proteins 0.000 description 1
VRGWBRLULZUWAJ-XFFXIZSCSA-N [(2s)-2-[(1r,3z,5s,8z,12z,15s)-5,17-dihydroxy-4,8,12,15-tetramethyl-16-oxo-18-bicyclo[13.3.0]octadeca-3,8,12,17-tetraenyl]propyl] acetate Chemical compound C1\C=C(C)/CC\C=C(C)/CC[C@H](O)\C(C)=C/C[C@@H]2C([C@@H](COC(C)=O)C)=C(O)C(=O)[C@]21C VRGWBRLULZUWAJ-XFFXIZSCSA-N 0.000 description 1
SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
230000019552 anatomical structure morphogenesis Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
239000012122 aqueous mounting media Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000006470 autoimmune attack Effects 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000008827 biological function Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000005388 borosilicate glass Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
230000023852 carbohydrate metabolic process Effects 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000012832 cell culture technique Methods 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
239000002771 cell marker Substances 0.000 description 1
239000013553 cell monolayer Substances 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000010001 cellular homeostasis Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
230000035602 clotting Effects 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
210000001608 connective tissue cell Anatomy 0.000 description 1
238000012303 cytoplasmic staining Methods 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000032459 dedifferentiation Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
150000002019 disulfides Chemical class 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000007877 drug screening Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
208000030172 endocrine system disease Diseases 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
102000013361 fetuin Human genes 0.000 description 1
108060002885 fetuin Proteins 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
VRGWBRLULZUWAJ-UHFFFAOYSA-N fusaproliferin Natural products C1C=C(C)CCC=C(C)CCC(O)C(C)=CCC2C(C(COC(C)=O)C)=C(O)C(=O)C21C VRGWBRLULZUWAJ-UHFFFAOYSA-N 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
108010034429 heregulin alpha Proteins 0.000 description 1
239000012145 high-salt buffer Substances 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
239000003688 hormone derivative Substances 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000008073 immune recognition Effects 0.000 description 1
238000003365 immunocytochemistry Methods 0.000 description 1
238000002991 immunohistochemical analysis Methods 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
102000027411 intracellular receptors Human genes 0.000 description 1
108091008582 intracellular receptors Proteins 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000006651 lactation Effects 0.000 description 1
229950008325 levothyroxine Drugs 0.000 description 1
239000003446 ligand Substances 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000012533 medium component Substances 0.000 description 1
239000012913 medium supplement Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
230000024799 morphogenesis of a branching structure Effects 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
230000021332 multicellular organism growth Effects 0.000 description 1
230000009707 neogenesis Effects 0.000 description 1
GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
210000005055 nestin Anatomy 0.000 description 1
108010023779 neurestin Proteins 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000008201 pancreatic cell development Effects 0.000 description 1
210000000277 pancreatic duct Anatomy 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
238000012247 phenotypical assay Methods 0.000 description 1
INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
102000003998 progesterone receptors Human genes 0.000 description 1
108090000468 progesterone receptors Proteins 0.000 description 1
229930185346 proliferin Natural products 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000005070 sampling Methods 0.000 description 1
210000004739 secretory vesicle Anatomy 0.000 description 1
MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
239000012090 serum-supplement Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
102000004217 thyroid hormone receptors Human genes 0.000 description 1
108090000721 thyroid hormone receptors Proteins 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical class OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
230000035899 viability Effects 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/305—Growth hormone [GH], aka. somatotropin

Landscapes

Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU2001273108A 2000-06-30 2001-06-29 Culturing pancreatic stem cells having a specified, intermediate stage of development Abandoned AU2001273108A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US21563400P	2000-06-30	2000-06-30
US60215634		2000-06-30
US24630600P	2000-11-06	2000-11-06
US60246306		2000-11-06
PCT/US2001/020906 WO2002002750A1 (fr)	2000-06-30	2001-06-29	Culture de cellules embryonnaires pancreatiques presentant un stade de developpement intermediaire specifie

Publications (1)

Publication Number	Publication Date
AU2001273108A1 true AU2001273108A1 (en)	2002-01-14

Family

ID=26910235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001273108A Abandoned AU2001273108A1 (en)	2000-06-30	2001-06-29	Culturing pancreatic stem cells having a specified, intermediate stage of development

Country Status (5)

Country	Link
EP (1)	EP1301589A4 (fr)
JP (1)	JP2004502425A (fr)
AU (1)	AU2001273108A1 (fr)
CA (1)	CA2415108A1 (fr)
WO (1)	WO2002002750A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7371576B2 (en)	2002-09-06	2008-05-13	Reneuron, Inc.	CD56 positive human adult pancreatic endocrine progenitor cells
ES2751095T3 (es) *	2004-04-27	2020-03-30	Viacyte Inc	Endodermo que expresa pdx1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK402984D0 (da) *	1984-08-23	1984-08-23	Nordisk Insulinlab	Fremgangsmaade til formering af insulin-producerende celler
DE69232535T4 (de) *	1991-06-24	2003-09-11	Hcell Technology, Inc.	In langzeitkultur gehaltene hormon-absondernde pankreatische zellen
AU739771B2 (en) *	1995-10-25	2001-10-18	University Of Florida Research Foundation, Inc.	In vitro growth of functional islets of langerhans and in vivo uses thereof
US5874306A (en) *	1996-12-12	1999-02-23	The Regents Of The University Of California	Culturing human pancreatic endocrine cells in medium containing extracellular matrix from human bladder carcinoma cells
EP1175487A2 (fr) *	1999-02-10	2002-01-30	Curis, Inc.	Cellules progenitrices de pancreas et procedes et utilisations associees
EP1185622A4 (fr) *	1999-06-23	2002-09-18	Joslin Diabetes Center Inc	Fabrication d'ilots de cellules pancreatiques

2001
- 2001-06-29 WO PCT/US2001/020906 patent/WO2002002750A1/fr not_active Ceased
- 2001-06-29 CA CA002415108A patent/CA2415108A1/fr not_active Abandoned
- 2001-06-29 JP JP2002507991A patent/JP2004502425A/ja active Pending
- 2001-06-29 AU AU2001273108A patent/AU2001273108A1/en not_active Abandoned
- 2001-06-29 EP EP01952344A patent/EP1301589A4/fr not_active Withdrawn

Also Published As

Publication number	Publication date
JP2004502425A (ja)	2004-01-29
EP1301589A1 (fr)	2003-04-16
EP1301589A4 (fr)	2004-06-16
WO2002002750A1 (fr)	2002-01-10
CA2415108A1 (fr)	2002-01-10

Publication	Publication Date	Title
US6759039B2 (en)	2004-07-06	Culturing pancreatic stem cells having a specified, intermediate stage of development
AU2002359874B2 (en)	2008-11-20	Cultured and encapsulated pancreatic stem cells
US7371576B2 (en)	2008-05-13	CD56 positive human adult pancreatic endocrine progenitor cells
AU2003302702B2 (en)	2008-08-07	Cultured human pancreatic islets, and uses thereof
CA2637843C (fr)	2014-12-30	Procede permettant d'ameliorer la proliferation cellulaire des cellules progenitrices pancreatiques dans une culture de cellules pancreatiques
US8377689B2 (en)	2013-02-19	EPHA4-positive human adult pancreatic endocrine progenitor cells
US20050064587A1 (en)	2005-03-24	Pancreatic small cells and uses thereof
US20050037490A1 (en)	2005-02-17	Medium for preparing dedifferentiated cells
US20240124843A1 (en)	2024-04-18	Functional feline pancreatic cells from adipose tissue
WO2003066832A2 (fr)	2003-08-14	Generation de nouvelles cellules d'insuline a partir de cellules souches presentes dans des ilots pancreatiques adultes
AU2001273108A1 (en)	2002-01-14	Culturing pancreatic stem cells having a specified, intermediate stage of development
MXPA02004268A (es)	2003-01-28	Medio para preparar celulas dediferenciadas.
Racanicchi et al.	2007	Neonatal Pig Liver–Derived Progenitors for Insulin-Producing Cells: An In Vitro Study
US20070015279A1 (en)	2007-01-18	Methods of Selecting Pancreatic Endocrine Cells Using Protein Synthesis Inhibitors
WO2007009356A1 (fr)	2007-01-25	Méthode pour détecter et cultiver des cellules pancréatiques et application

Legal Events

Date	Code	Title	Description
2007-05-03	MK5	Application lapsed section 142(2)(e) - patent request and compl. specification not accepted